Skip to main content
OpenTrials

Clinical trial condition

CCND1 Gene Amplification

Explore clinical trials studying CCND1 Gene Amplification. Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies
Refine in advanced search Browse all conditions

CCND1 Gene Amplification trial results

Completed

Lung-MAP: Palbociclib as Second-Line Therapy in Treating Cell Cycle Gene Alteration Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

NCT02785939

Conditions
CCND1 Gene Amplification, CCND2 Gene Amplification, CCND3 Gene Amplification, +3 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
View all 1065 locations
View Trial Details

Related conditions